Family Medicine · Oakland, TN
NPI
1285658237
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
7243 Highway 64
Oakland, TN, 38060
Phone (901) 465-9902
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
6,363 services
Medicare patients, 2024
249
Average age 71
Drug cost, 2024
$706K
11,569 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Darrin Lyons was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,433 times for 46 patients. In total Darrin Lyons billed 6,363 services in 38 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,433 | 46 | $0.10 | $138 |
| 99214 Office E&M - Established | Office | 454 | 199 | $76.77 | $35K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 445 | 58 | $0.31 | $139 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 438 | 53 | $0.08 | $33.34 |
| 96372 Injection Administration | Office | 270 | 73 | $9.17 | $2,477 |
| 99213 Office E&M - Established | Office | 220 | 109 | $53.97 | $12K |
| 83036 Blood Count | Office | 96 | 61 | $9.42 | $904 |
| 82962 Clinical Chemistry | Office | 79 | 50 | $3.18 | $251 |
| 93000 Electrocardiogram | Office | 66 | 61 | $7.92 | $523 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 60 | 60 | $119.58 | $7,175 |
| 81003 Clinical Chemistry | Office | 49 | 43 | $2.12 | $104 |
| 87811 Immunoassay | Office | 43 | 33 | $39.61 | $1,703 |
| 87804 Immunoassay | Office | 40 | 19 | $15.41 | $616 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 24 | 19 | $2.41 | $57.72 |
| 99203 Office E&M - New | Office | 19 | 19 | $43.32 | $823 |
By year: 2022 $66K for 2,921 services; 2023 $65K for 2,822 services; 2024 $64K for 6,363 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 96 | 61 | $9.42 | $904 |
| 82962 Clinical Chemistry | 79 | 50 | $3.18 | $251 |
| 81003 Clinical Chemistry | 49 | 43 | $2.12 | $104 |
| 87811 Immunoassay | 43 | 33 | $39.61 | $1,703 |
| 87804 Immunoassay | 40 | 19 | $15.41 | $616 |
| 87880 Immunoassay | 11 | 11 | $16.20 | $178 |
Medicare prescription drug claims, 2024
In 2024, the drug Darrin Lyons prescribed most often to Medicare patients was Montelukast Sodium, with 705 prescriptions and refills. In total Darrin Lyons wrote 11,569 Medicare prescriptions that cost $706K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 705 | 1,215 | 197 | $10K |
| Amlodipine Besylate Generic | 482 | 1,279 | 144 | $2,479 |
| Omeprazole Generic | 476 | 867 | 107 | $7,483 |
| Azithromycin Generic | 427 | 427 | 189 | $2,382 |
| Simvastatin Generic | 411 | 869 | 93 | $3,958 |
| Losartan Potassium Generic | 368 | 941 | 109 | $3,285 |
| Atorvastatin Calcium Generic | 357 | 940 | 106 | $3,781 |
| Prednisone Generic | 319 | 319 | 163 | $785 |
| Levothyroxine Sodium Generic | 272 | 542 | 55 | $2,160 |
| Potassium Chloride Generic | 253 | 508 | 63 | $5,025 |
| Rosuvastatin Calcium Generic | 248 | 611 | 93 | $4,156 |
| Metformin Hcl Generic | 239 | 584 | 68 | $1,151 |
| Tamsulosin Hcl Generic | 217 | 428 | 54 | $3,177 |
| Gabapentin Generic | 207 | 229 | 55 | $1,512 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 190 | 201 | 59 | $5,502 |
Brand drugs: 1,129 claims; generic drugs: 10,365 claims; opioid claims: 162.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Darrin Lyons were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.